Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE.

Saved in:
Bibliographic Details
Title: Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE.
Authors: Stevenson MD; Sheffield Centre for Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK. m.d.stevenson@sheffield.ac.uk., Mon-Yee M; Sheffield Centre for Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK., Forsyth JE; Sheffield Centre for Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK., Montazeri A; The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, UK., Saunders MP; The Christie, Wilmslow Road, Manchester, M20 4BX, UK.
Source: Cost effectiveness and resource allocation : C/E [Cost Eff Resour Alloc] 2026 May 12; Vol. 24 (1). Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101170476 Publication Model: Electronic Cited Medium: Print ISSN: 1478-7547 (Print) Linking ISSN: 14787547 NLM ISO Abbreviation: Cost Eff Resour Alloc Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1478-7547
DOI:10.1186/s12962-026-00761-w